Arcadia Biosciences discloses $169K discretionary bonus to CEO Schaefer for 2025; sets 2026 annual meeting for Sept 10

Arcadia Biosciences, Inc.

CEO Thomas Schaefer received $169,000 discretionary cash bonus for 2025; no other NEOs received bonus.
Schaefer's total 2025 compensation: $473,058 (salary $260K, bonus $169K, option awards $40K, other $4K).
2026 annual meeting set for September 10, 2026; stockholder proposals due by July 13, 2026.
Company did not pay bonuses under Executive Incentive Bonus Plan for 2025 due to terminated business combination transaction.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.